Eton Pharmaceuticals Files 8-K on Financials
Ticker: ETON · Form: 8-K · Filed: Aug 8, 2024 · CIK: 1710340
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Eton Pharma dropped an 8-K, check the financials.
AI Summary
Eton Pharmaceuticals, Inc. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, providing an update on the company's financial performance. No specific dollar amounts or significant events were detailed in the provided excerpt.
Why It Matters
This filing provides investors with an update on Eton Pharmaceuticals' financial health and operational results, which can influence investment decisions.
Risk Assessment
Risk Level: low — The filing is a routine financial disclosure and does not indicate any immediate or significant risks.
Key Players & Entities
- Eton Pharmaceuticals, Inc. (company) — Registrant
- August 8, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Deer Park, Illinois (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Eton Pharmaceuticals?
The primary purpose is to report on Eton Pharmaceuticals, Inc.'s results of operations and financial condition, as indicated by the 'ITEM INFORMATION' section.
On what date was this 8-K filing submitted?
The filing was submitted on August 8, 2024.
What is Eton Pharmaceuticals' state of incorporation?
Eton Pharmaceuticals, Inc. is incorporated in Delaware.
Where are Eton Pharmaceuticals' principal executive offices located?
The principal executive offices are located at 21925 W. Field Parkway, Suite 235, Deer Park, Illinois 60010-7208.
What is the SIC code for Eton Pharmaceuticals?
The Standard Industrial Classification (SIC) code for Eton Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 498 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2024-08-08 16:21:24
Key Financial Figures
- $0.001 — h registered Common Stock , par value $0.001 per share ETON NASDAQ Global Market
Filing Documents
- eton20240802_8k.htm (8-K) — 26KB
- ex_707871.htm (EX-99.1) — 155KB
- 0001437749-24-025569.txt ( ) — 327KB
- eton-20240808.xsd (EX-101.SCH) — 3KB
- eton-20240808_def.xml (EX-101.DEF) — 12KB
- eton-20240808_lab.xml (EX-101.LAB) — 15KB
- eton-20240808_pre.xml (EX-101.PRE) — 12KB
- eton20240802_8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 8, 2024 By: /s/ James R. Gruber James R. Gruber Chief Financial Officer and Secretary (Principal Financial Officer) 4